1008
Pathogenesis of Chronic Rhinosinusitis
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 502A
2.50 CME/CE
Course
Moderator:
Tanya M. Laidlaw , MD FAAAAI

Learning Objectives:
  1. Discuss the role of TSLP and its metabolic products in the inflammation of nasal polyps
  2. Recognize the mechanisms by which IL-33 contributes to the pathogenesis of CRS with nasal polyps and the potential to target this cytokine in therapy
  3. Identify the mechanisms by which PGD2 directs inflammation in rhinosinusitis and nasal polyps and become aware of unique aspects of the pathology and pathophysiology of nasal polyp disease in Asia and in Europe
7:00 AM
Role of TSLP in Chronic Rhinosinusitis with Nasal Polyps
Atsushi Kato, PhD
7:20 AM
Question & Answer
7:30 AM
Role of IL-33 in Chronic Rhinosinusitis with Nasal Polyps
Joshua A. Boyce, MD FAAAAI
7:50 AM
Question & Answer
8:00 AM
Role of Prostaglandin D2 in Chronic Rhinosinusitis with Nasal Polyps
Katherine N. Cahill, MD
8:20 AM
Question & Answer
8:30 AM
Role of the Microbiome in Chronic Rhinosinusitis and Risk of Nasal Polyposis
Marek L. Kowalski, MD PhD
8:50 AM
Question & Answer
9:00 AM
Role of Staphylococcus Aureus in Chronic Rhinosinusitis with Nasal Polyps
Claus Bachert, MD PhD
9:20 AM
Question & Answer
See more of: Session